Results 181 to 190 of about 1,912,527 (212)

Using body composition to predict treatment-related adverse events and disease-free survival in patients with gastrointestinal stromal tumors treated with imatinib: a retrospective cohort study. [PDF]

Front Immunol
Gu T, Li T, Zhang J, Zhou Q, Yang D, Xu J, Li Q, Xu Z, Li F, Xu H.   +9 more
europepmc   +1 more source

Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab. [PDF]

NPJ Breast Cancer
Chew SM, Ferraro E, Chen Y, Barrio AV, Kelly D, Modi S, Seidman AD, Wen H, Brogi E, Robson M, Dang CT.   +10 more
europepmc   +1 more source

Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial.

JAMA
Zeng Z, Luo S, Zhang H, Wu M, Ma D, Wang Q, Xie M, Xu Q, Ouyang J, Xiao Y, Song Y, Feng B, Xu Q, Wang Y, Zhang Y, Shi L, Ling L, Zhang X, Huang L, Yang Z, Peng J, Wu X, Ren D, Huang M, Lan P, Wang J, Tong W, Ren M, Liu H, Kang L, Chinese Transanal Endoscopic Surgery Collaborative (CTESC) Group.   +30 more
europepmc   +1 more source

Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis. [PDF]

J Neurooncol
Wang Q, Wang H, Hong W, Bashir S, Hua X, Yang Y, Zhen J, Li J, Lai M, Cai L.   +9 more
europepmc   +1 more source

Predicting disease-free survival following curative-intent resection of right-sided colon cancer using a pre- and post-operative nomogram: a prospective observational cohort study. [PDF]

Int J Surg
Lucocq J, Trinder T, Homyer K, Baig H, Patil P, Muthukumarasamy G.   +5 more
europepmc   +1 more source

The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer. [PDF]

BMC Cancer
Şen GA, Aydın E, Guliyev M, Öztaş NŞ, Değerli E, Demirci NS, Turna ZH, Demirelli FH.   +7 more
europepmc   +1 more source

Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data. [PDF]

ESMO Open
Ajani JA, Leung L, Kanters S, Singh P, Kurt M, Kim I, Pourrahmat MM, Friedman HS, Navaratnam P, Reardon G.   +9 more
europepmc   +1 more source

Preventive dendritic cell vaccination induced TGF-βRII frameshift neoantigen-specific T-cells are linked to long-term disease-free survival in Lynch Syndrome patients

De Vries IJM, Abidi A, Westdorp H, Gorris M, Boudewijns S, Wimmers F, Bisseling T, Pinxteren MvV, Nagengast F, de Goede A, Rossum Mv, Kuiper RP, Bladergroen R, Croockewit A, Ligtenberg M, Nagtegaal I, Figdor C, Gerritsen W, Schreibelt G, Hoogerbrugge N.   +19 more
europepmc   +1 more source

Disease-free survival of 15 years after primary surgery in a patient with advanced high-grade serous ovarian cancer: a case report and literature review. [PDF]

Front Oncol
Shi Y, Zhu S, Shan J, Xu Y.
europepmc   +1 more source

Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy. [PDF]

J Immunother Cancer
Toney NJ, Lynch MT, Lynce F, Mainor C, Isaacs C, Schlom J, Donahue RN.   +6 more
europepmc   +1 more source